BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30086417)

  • 1. Thiazolo[3,2-a]pyrimidin-5-one derivatives as a novel class of 11β-hydroxysteroid dehydrogenase inhibitors.
    Studzińska R; Kupczyk D; Płazińska A; Kołodziejska R; Kosmalski T; Modzelewska-Banachiewicz B
    Bioorg Chem; 2018 Dec; 81():21-26. PubMed ID: 30086417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel derivatives of thiazol-4(5H)-one and their activity in the inhibition of 11β-hydroxysteroid dehydrogenase type 1.
    Studzińska R; Kołodziejska R; Kupczyk D; Płaziński W; Kosmalski T
    Bioorg Chem; 2018 Sep; 79():115-121. PubMed ID: 29738970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 2-(Adamantan-1-ylamino)Thiazol-4(5
    Studzińska R; Kupczyk D; Płaziński W; Baumgart S; Bilski R; Paprocka R; Kołodziejska R
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzothiazole derivatives as novel inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1.
    Su X; Vicker N; Ganeshapillai D; Smith A; Purohit A; Reed MJ; Potter BV
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):214-7. PubMed ID: 16325333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of the N-methyl Derivatives of 2-Aminothiazol-4(5H)-one and Their Interactions with 11βHSD1-Molecular Modeling and in Vitro Studies.
    Studzińska R; Kołodziejska R; Płaziński W; Kupczyk D; Kosmalski T; Jasieniecka K; Modzelewska-Banachiewicz B
    Chem Biodivers; 2019 Jun; 16(6):e1900065. PubMed ID: 31012543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel 11β-HSD1 inhibitors by combined ligand- and structure-based virtual screening.
    Lagos CF; Vecchiola A; Allende F; Fuentes CA; Tichauer JE; Valdivia C; Solari S; Campino C; Tapia-Castillo A; Baudrand R; Villarroel P; Cifuentes M; Owen GI; Carvajal CA; Fardella CE
    Mol Cell Endocrinol; 2014 Mar; 384(1-2):71-82. PubMed ID: 24447464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of chenodeoxycholic acid on 11beta-hydroxysteroid dehydrogenase in various target tissues.
    Morris DJ; Souness GW; Latif SA; Hardy MP; Brem AS
    Metabolism; 2004 Jun; 53(6):811-6. PubMed ID: 15164334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of adamantyl ethanone derivatives as potent 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitors.
    Su X; Pradaux-Caggiano F; Thomas MP; Szeto MW; Halem HA; Culler MD; Vicker N; Potter BV
    ChemMedChem; 2010 Jul; 5(7):1026-44. PubMed ID: 20486152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of Novel 2-(Isopropylamino)thiazol-4(5
    Kupczyk D; Studzińska R; Bilski R; Baumgart S; Kołodziejska R; Woźniak A
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32942682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders?
    Anagnostis P; Katsiki N; Adamidou F; Athyros VG; Karagiannis A; Kita M; Mikhailidis DP
    Metabolism; 2013 Jan; 62(1):21-33. PubMed ID: 22652056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 1 11beta-hydroxysteroid dehydrogenase as universal drug target in metabolic diseases?
    Oppermann U
    Endocr Metab Immune Disord Drug Targets; 2006 Sep; 6(3):259-69. PubMed ID: 17017977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rapid screening assay for inhibitors of 11beta-hydroxysteroid dehydrogenases (11beta-HSD): flavanone selectively inhibits 11beta-HSD1 reductase activity.
    Schweizer RA; Atanasov AG; Frey BM; Odermatt A
    Mol Cell Endocrinol; 2003 Dec; 212(1-2):41-9. PubMed ID: 14654249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of adamantyl heterocyclic ketones as potent 11β-hydroxysteroid dehydrogenase type 1 inhibitors.
    Su X; Vicker N; Thomas MP; Pradaux-Caggiano F; Halem H; Culler MD; Potter BV
    ChemMedChem; 2011 Aug; 6(8):1439-51. PubMed ID: 21608132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metyrapone is a competitive inhibitor of 11beta-hydroxysteroid dehydrogenase type 1 reductase.
    Sampath-Kumar R; Yu M; Khalil MW; Yang K
    J Steroid Biochem Mol Biol; 1997 Jun; 62(2-3):195-9. PubMed ID: 9393954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel non-steroidal inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1.
    Vicker N; Su X; Ganeshapillai D; Smith A; Purohit A; Reed MJ; Potter BV
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):123-9. PubMed ID: 17482805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and biological evaluation of novel selective peptide inhibitors of 11β-hydroxysteroid dehydrogenase 1.
    Boudon S; Heidl M; Vuorinen A; Wandeler E; Campiche R; Odermatt A; Jackson E
    Bioorg Med Chem; 2018 Oct; 26(18):5128-5139. PubMed ID: 30245006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of novel 3-amino and 29-hydroxamic acid derivatives of glycyrrhetinic acid as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
    Stanetty C; Czollner L; Koller I; Shah P; Gaware R; Cunha TD; Odermatt A; Jordis U; Kosma P; Classen-Houben D
    Bioorg Med Chem; 2010 Nov; 18(21):7522-41. PubMed ID: 20851614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, molecular docking and in vitro evaluation of benzothiazole derivatives as 11β-hydroxysteroid dehydrogenase type 1 inhibitors.
    Cabrera Pérez LC; Padilla-Martínez II; Cruz A; Correa Basurto J; Miliar García Á; Hernández Zavala AA; Gómez López M; Rosales Hernández MC
    Mol Divers; 2020 Nov; 24(4):1-14. PubMed ID: 31664610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active site variability of type 1 11beta-hydroxysteroid dehydrogenase revealed by selective inhibitors and cross-species comparisons.
    Hult M; Shafqat N; Elleby B; Mitschke D; Svensson S; Forsgren M; Barf T; Vallgårda J; Abrahmsen L; Oppermann U
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):26-33. PubMed ID: 16431016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of 2-{2-[(α/β-naphthalen-1-ylsulfonyl)amino]-1,3-thiazol-4-yl} acetamides with 11β-hydroxysteroid dehydrogenase inhibition and in combo antidiabetic activities.
    Navarrete-Vázquez G; Morales-Vilchis MG; Estrada-Soto S; Ramírez-Espinosa JJ; Hidalgo-Figueroa S; Nava-Zuazo C; Tlahuext H; Leon-Rivera I; Medina-Franco JL; López-Vallejo F; Webster SP; Binnie M; Ortiz-Andrade R; Moreno-Diaz H
    Eur J Med Chem; 2014 Mar; 74():179-86. PubMed ID: 24462849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.